Effect of Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine on Exacerbation Rate and Risk in Patients With Moderate to Severe COPD

Riccardi V, Viscomi CF, Sandri M, D'Alessandro A, Dzieciatkowska M, Stephenson D, Federti E, Hermann A, Salviati L, Siciliano A, Andolfo I, Alper SL, Ceolan[...]

Chotard M, Wang X, Zheng X, Kaye TG, Grosmougin M, Barlow L, Kundrát M, Dececchi TA, Habib MB, Zariwala J, Hartman S, Xu X, Pittman[...]

Klein R, Julian KA, Alba-Nguyen S, Ufere NN, Jassal SK, Simon W, Millard A, Uthlaut B, Koch J, Snyder ED, Volerman A, Thompson V, Kumar[...]